Evidence map›Paper›PMID 23818846›Full record

Trial reportPLoS pathogens2013

Novel polyomaviruses of nonhuman primates: genetic and serological predictors for the existence of multiple unknown polyomaviruses within the human population.

Nelly Scuda, Nadege Freda Madinda, Chantal Akoua-Koffi, Edgard Valerie Adjogoua, Diana Wevers, Jörg Hofmann, Kenneth N Cameron, Siv Aina J Leendertz, Emmanuel Couacy-Hymann, Martha Robbins and 7 more

Open access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in PLoS pathogens, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Viruses in sanctuary chimpanzees across Africa.American journal of primatology · 2023
    Article
  5. Review
  6. Viral diversity in oral cavity from Sapajus nigritus by metagenomic analyses.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2020
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 6 countries.

Nelly ScudaDepartment of Infectious Diseases, Robert Koch Institute, Berlin, Germany.
Nadege Freda Madinda
Chantal Akoua-Koffi
Edgard Valerie Adjogoua
Diana Wevers
Jörg Hofmann
Kenneth N Cameron
Siv Aina J Leendertz
Emmanuel Couacy-Hymann
Martha Robbins
Christophe Boesch
Michael A Jarvis
Ugo Moens
Lawrence Mugisha
Sébastien Calvignac-Spencer
Fabian H Leendertz
Bernhard Ehlers
Robert Koch Institute · DELaboratoire National d'Appui au Développement Agricole · CIBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DEConservation and Ecosystem Health Alliance · UGGorilla Doctors · USInstitut Pasteur de Côte d'Ivoire · CIMax Planck Institute for Evolutionary Anthropology · DEUiT The Arctic University of Norway · NOUniversité Alassane Ouattara · CIUniversity of Plymouth · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polyomaviruses are a family of small non-enveloped DNA viruses that encode oncogenes and have been associated, to greater or lesser extent, with human disease and cancer. Currently, twelve polyomaviruses are known to circulate within the human population. To further examine the diversity of human polyomaviruses, we have utilized a combinatorial approach comprised of initial degenerate primer-based PCR identification and phylogenetic analysis of nonhuman primate (NHP) polyomavirus species, followed by polyomavirus-specific serological analysis of human sera. Using this approach we identified twenty novel NHP polyomaviruses: nine in great apes (six in chimpanzees, two in gorillas and one in orangutan), five in Old World monkeys and six in New World monkeys. Phylogenetic analysis indicated that only four of the nine chimpanzee polyomaviruses (six novel and three previously identified) had known close human counterparts. To determine whether the remaining chimpanzee polyomaviruses had potential human counterparts, the major viral capsid proteins (VP1) of four chimpanzee polyomaviruses were expressed in E. coli for use as antigens in enzyme-linked immunoassay (ELISA). Human serum/plasma samples from both Côte d'Ivoire and Germany showed frequent seropositivity for the four viruses. Antibody pre-adsorption-based ELISA excluded the possibility that reactivities resulted from binding to known human polyomaviruses. Together, these results support the existence of additional polyomaviruses circulating within the human population that are genetically and serologically related to existing chimpanzee polyomaviruses.

Indexed as

PhylogenyAnimalsAntibodies, ViralCapsid ProteinsEnzyme-Linked Immunosorbent AssayFemaleHumansMaleMonkey DiseasesPlatyrrhiniPolyomavirusPolyomavirus InfectionsAntibodies, ViralCapsid ProteinsVP1 protein, polyomavirus

Identifiers

PMID23818846
PMCPMC3688531
OpenAlexW1988574176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.